| Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? RJ Johnson, DH Kang, D Feig, S Kivlighn, J Kanellis, S Watanabe, ... hypertension 41 (6), 1183-1190, 2003 | 2264 | 2003 |
| Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism M Mazzali, J Kanellis, L Han, L Feng, YY Xia, Q Chen, DH Kang, ... American Journal of Physiology-Renal Physiology 282 (6), F991-F997, 2002 | 1211 | 2002 |
| Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 J Kanellis, S Watanabe, JH Li, DH Kang, P Li, T Nakagawa, A Wamsley, ... Hypertension 41 (6), 1287-1293, 2003 | 1139 | 2003 |
| Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity S Watanabe, DH Kang, L Feng, T Nakagawa, J Kanellis, H Lan, ... Hypertension 40 (3), 355-360, 2002 | 888 | 2002 |
| Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease J Kanellis, DH Kang Seminars in nephrology 25 (1), 39-42, 2005 | 698 | 2005 |
| Role of the microvascular endothelium in progressive renal disease DH Kang, J Kanellis, C Hugo, L Truong, S Anderson, D Kerjaschki, ... Journal of the American Society of Nephrology 13 (3), 806-816, 2002 | 683 | 2002 |
| Hyperuricemia causes glomerular hypertrophy in the rat T Nakagawa, M Mazzali, DH Kang, J Kanellis, S Watanabe, ... American journal of nephrology 23 (1), 2-7, 2002 | 424 | 2002 |
| Effects of allopurinol on the progression of chronic kidney disease SV Badve, EM Pascoe, A Tiku, N Boudville, FG Brown, A Cass, P Clarke, ... New England Journal of Medicine 382 (26), 2504-2513, 2020 | 361 | 2020 |
| Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency DB Corry, K Rishi, J Kanellis, A Kiss, L Song, J Xu, L Feng, Z Werb, ... Nature immunology 3 (4), 347-353, 2002 | 314 | 2002 |
| Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter DH Kang, L Han, X Ouyang, AM Kahn, J Kanellis, P Li, L Feng, ... American journal of nephrology 25 (5), 425-433, 2005 | 292 | 2005 |
| Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis B Bose, SV Badve, SS Hiremath, N Boudville, FG Brown, A Cass, ... Nephrology Dialysis Transplantation 29 (2), 406-413, 2014 | 259 | 2014 |
| Everolimus with reduced calcineurin inhibitor exposure in renal transplantation J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ... Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018 | 257 | 2018 |
| Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link DH Kang, J Finch, T Nakagawa, SA Karumanchi, J Kanellis, J Granger, ... Journal of hypertension 22 (2), 229-235, 2004 | 216 | 2004 |
| Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells J Kanellis, S Fraser, M Katerelos, DA Power American Journal of Physiology-Renal Physiology 278 (6), F905-F915, 2000 | 172 | 2000 |
| The motivations and experiences of living kidney donors: a thematic synthesis A Tong, JR Chapman, G Wong, J Kanellis, G McCarthy, JC Craig American Journal of Kidney Diseases 60 (1), 15-26, 2012 | 165 | 2012 |
| A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients WH Lim, J Eris, J Kanellis, B Pussell, Z Wiid, D Witcombe, GR Russ American Journal of Transplantation 14 (9), 2106-2119, 2014 | 160 | 2014 |
| Understanding crossmatch testing in organ transplantation: A case‐based guide for the general nephrologist WR Mulley, J Kanellis Nephrology 16 (2), 125-133, 2011 | 140 | 2011 |
| Increased expression of heparanase in puromycin aminonucleoside nephrosis V Levidiotis, J Kanellis, FL Ierino, DA Power Kidney International 60 (4), 1287-1296, 2001 | 122 | 2001 |
| Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized … WH Marks, N Mamode, RA Montgomery, MD Stegall, LE Ratner, ... American Journal of Transplantation 19 (10), 2876-2888, 2019 | 112 | 2019 |
| Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial L Rostaing, S Bunnapradist, JM Grinyó, K Ciechanowski, JE Denny, ... American Journal of Kidney Diseases 67 (4), 648-659, 2016 | 102 | 2016 |
